Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis

Studies comparing the effects of natalizumab and fingolimod in relapsing–remitting multiple sclerosis (RRMS) are limited. We aimed to compare natalizumab and fingolimod effects on clinical, neuropsychological, and MRI measures in RRMS patients after 2 years of treatment. RRMS patients starting natal...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurotherapeutics
Hlavní autoři: Preziosa, Paolo, Rocca, Maria A., Riccitelli, Gianna C., Moiola, Lucia, Storelli, Loredana, Rodegher, Mariaemma, Comi, Giancarlo, Signori, Alessio, Falini, Andrea, Filippi, Massimo
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007466/
https://ncbi.nlm.nih.gov/pubmed/31452082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00781-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky